US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 4.140
  • -0.020-0.48%
Close Jul 22 16:00 ET
  • 4.250
  • +0.110+2.66%
Post 16:39 ET
124.92MMarket Cap-1322P/E (TTM)

Relmada Therapeutics Key Stats

Relmada Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.72

+17.24%

Buy

Jun 30, 2024

Relmada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/Q3-- / 0.000--
--2020/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2020/Q3-- / 0.000--
--2020/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Relmada Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 30, 2024

Buy

  • Buy

    66.67%
  • Hold

    0.00%
  • Sell

    33.33%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg